# Marathon Bancorp, Inc.: financial statements, quarterly

MBBC · Nasdaq · CIK 1835385 · [Financials](/sectors/financials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/mbbc.md) · [Financials](/companies/mbbc/financials.md) · [Filings](/companies/mbbc/filings.md) · [Insiders](/companies/mbbc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mbbc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [842](/filings/0001558370-23-019040.md) | [917](/filings/0001558370-24-001113.md) | [916](/filings/0001558370-24-007973.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [201](/filings/0001558370-24-015434.md) | [(29.2)](/filings/0001558370-25-000901.md) | [(203)](/filings/0001558370-25-007658.md) | [(28.4) d](/filings/0001104659-25-093884.md) | [40.6](/filings/0001104659-25-109769.md) | [1.5](/filings/0001104659-26-013033.md) | [45.4](/filings/0001104659-26-059789.md) | [(119) d](/filings/0001104659-26-108076.md) | [103](/filings/0001104659-25-109769.md) | [87.2](/filings/0001104659-26-013033.md) | [121](/filings/0001104659-26-059789.md) | [29.7 d](/filings/0001104659-26-108076.md) |
| Net income | $k | [86.2](/filings/0001558370-25-007658.md) | [272](/filings/0001558370-25-007658.md) | [(631)](/filings/0001558370-25-007658.md) | [85.8 d](/filings/0001104659-25-093884.md) | [175](/filings/0001104659-26-059789.md) | [51.1](/filings/0001104659-26-059789.md) | [148](/filings/0001104659-26-059789.md) | [(332) d](/filings/0001104659-26-108076.md) | [444](/filings/0001104659-26-059789.md) | [501](/filings/0001104659-26-059789.md) | [488](/filings/0001104659-26-059789.md) | [358 d](/filings/0001104659-26-108076.md) |
| Diluted EPS | $ per share | [0.04](/filings/0001558370-24-015434.md) | [0.13](/filings/0001558370-25-000901.md) | [(0.31)](/filings/0001558370-25-007658.md) | not reported | [0.06](/filings/0001104659-25-109769.md) | [0.02](/filings/0001104659-26-013033.md) | [0.05](/filings/0001104659-26-059789.md) | not reported | [0.17](/filings/0001104659-25-109769.md) | [0.19](/filings/0001104659-26-013033.md) | [0.18](/filings/0001104659-26-059789.md) | not reported |
| Basic EPS | $ per share | [0.04](/filings/0001558370-24-015434.md) | [0.13](/filings/0001558370-25-000901.md) | [(0.31)](/filings/0001558370-25-007658.md) | not reported | [0.06](/filings/0001104659-25-109769.md) | [0.02](/filings/0001104659-26-013033.md) | [0.05](/filings/0001104659-26-059789.md) | not reported | [0.17](/filings/0001104659-25-109769.md) | [0.19](/filings/0001104659-26-013033.md) | [0.18](/filings/0001104659-26-059789.md) | not reported |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | [236](/filings/0001558370-23-019040.md) | [234](/filings/0001558370-24-001113.md) | [226](/filings/0001558370-24-007973.md) | [219](/filings/0001104659-25-093884.md) | [216](/filings/0001558370-24-015434.md) | [218](/filings/0001558370-25-000901.md) | [237](/filings/0001558370-25-007658.md) | [239](/filings/0001104659-26-108076.md) | [246](/filings/0001104659-25-109769.md) | [248](/filings/0001104659-26-013033.md) | [249](/filings/0001104659-26-059789.md) | [261](/filings/0001104659-26-108076.md) |
| Total liabilities | $m | [204](/filings/0001558370-23-019040.md) | [202](/filings/0001558370-24-001113.md) | [195](/filings/0001558370-24-007973.md) | [188](/filings/0001104659-25-093884.md) | [185](/filings/0001558370-24-015434.md) | [186](/filings/0001558370-25-000901.md) | [205](/filings/0001558370-25-007658.md) | [193](/filings/0001104659-26-108076.md) | [200](/filings/0001104659-25-109769.md) | [201](/filings/0001104659-26-013033.md) | [201](/filings/0001104659-26-059789.md) | [213](/filings/0001104659-26-108076.md) |
| Short-term borrowings | $m | not reported | not reported | [0.0](/filings/0001558370-24-007973.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [31.5](/filings/0001558370-25-007658.md) | [31.9](/filings/0001558370-25-007658.md) | [31.4](/filings/0001558370-25-007658.md) | [31.3](/filings/0001104659-26-108076.md) | [31.6](/filings/0001104659-26-059789.md) | [31.7](/filings/0001104659-26-059789.md) | [32.0](/filings/0001104659-26-059789.md) | [45.7](/filings/0001104659-26-108076.md) | [46.3](/filings/0001104659-26-059789.md) | [46.9](/filings/0001104659-26-059789.md) | [47.5](/filings/0001104659-26-059789.md) | [48.0](/filings/0001104659-26-108076.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [367](/filings/0001558370-24-015434.md) | [623 d](/filings/0001558370-25-000901.md) | [(802) d](/filings/0001558370-25-007658.md) | [229 d](/filings/0001104659-25-093884.md) | [945](/filings/0001104659-25-109769.md) | [114 d](/filings/0001104659-26-013033.md) | [849 d](/filings/0001104659-26-059789.md) | [(459) d](/filings/0001104659-26-108076.md) | [464](/filings/0001104659-25-109769.md) | [1,413 d](/filings/0001104659-26-013033.md) | [126 d](/filings/0001104659-26-059789.md) | [449 d](/filings/0001104659-26-108076.md) |
| Capital expenditure | $k | [1,648](/filings/0001558370-24-015434.md) | [346 d](/filings/0001558370-25-000901.md) | [252 d](/filings/0001558370-25-007658.md) | [19.5 d](/filings/0001104659-25-093884.md) | [23.7](/filings/0001104659-25-109769.md) | [8.6 d](/filings/0001104659-26-013033.md) | [75.8 d](/filings/0001104659-26-059789.md) | [70.9 d](/filings/0001104659-26-108076.md) | [7.3](/filings/0001104659-25-109769.md) | [14.0 d](/filings/0001104659-26-013033.md) | [15.6 d](/filings/0001104659-26-059789.md) | [395 d](/filings/0001104659-26-108076.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | [44.5](/filings/0001104659-25-109769.md) | [0.0 d](/filings/0001104659-26-013033.md) | [0.0 d](/filings/0001104659-26-059789.md) | [37.7 d](/filings/0001104659-26-108076.md) | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [2,148](/filings/0001558370-23-019040.md) | [2,153](/filings/0001558370-24-001113.md) | [2,105](/filings/0001558370-24-007973.md) | [2,046](/filings/0001558370-24-015434.md) | [2,044](/filings/0001558370-25-000901.md) | [2,045](/filings/0001558370-25-007658.md) | [2,794](/filings/0001104659-25-109769.md) | [2,794](/filings/0001104659-26-013033.md) | [2,826](/filings/0001104659-26-059789.md) | [2,690](/filings/0001104659-25-109769.md) | [2,699](/filings/0001104659-26-013033.md) | [2,744](/filings/0001104659-26-059789.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 3,009,903 at 2026-09-15, from the cover of the [10-K filed 2026-09-16](/filings/0001104659-26-108076.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.